ID
12807
Description
Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in Children; ODM derived from: https://clinicaltrials.gov/show/NCT01593488
Link
https://clinicaltrials.gov/show/NCT01593488
Keywords
Versions (1)
- 12/21/15 12/21/15 -
Uploaded on
December 21, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Lymphoblastic Leukemia NCT01593488
Eligibility Acute Lymphoblastic Leukemia NCT01593488
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
eligibility for aieop studies
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0013893
- UMLS CUI [1,2]
- C0173324
Description
study subject participation status
Data type
boolean
Alias
- UMLS CUI [1]
- C2348568
Description
neurologic toxicities
Data type
boolean
Alias
- UMLS CUI [1]
- C3160947
Description
coagulopathy
Data type
boolean
Alias
- UMLS CUI [1]
- C0005779
Description
sepsis
Data type
boolean
Alias
- UMLS CUI [1]
- C0243026
Description
intrathecal therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C1831734
Description
radiation therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0205918
Description
bone marrow transplant
Data type
boolean
Alias
- UMLS CUI [1]
- C0005961
Similar models
Eligibility Acute Lymphoblastic Leukemia NCT01593488
- StudyEvent: Eligibility
C0023449 (UMLS CUI [2])
C0173324 (UMLS CUI [1,2])